v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Feb. 28, 2026
Aug. 31, 2025
Current assets    
Cash and cash equivalents $ 5,391,821 $ 6,555,642
Deferred research and development costs 34,274 30,687
Prepaid expenses and other current assets 79,028 15,836
Total current assets 5,505,123 6,602,165
Property and Equipment, net 64,167 43,089
Total assets 5,569,290 6,645,254
Current liabilities    
Accounts payable and accrued expenses 187,688 114,309
Related party payables 90,701 79,866
Total current liabilities 278,389 194,175
Total liabilities 278,389 194,175
Stockholders' equity    
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding
Common stock: $0.001 par value; 300,000,000 shares authorized, 65,779,045 shares issued and outstanding at February 28, 2026 and August 31, 2025 65,779 65,779
Additional paid-in capital 87,475,862 87,475,862
Accumulated deficit (82,250,740) (81,090,562)
Total stockholders' equity 5,290,901 6,451,079
Total liabilities and stockholders' equity $ 5,569,290 $ 6,645,254